Keyur Shah, MD, a cardiologist, encourages patients to bring clinical and research information to their healthcare providers and highlights the importance of staying informed as amyloidosis care continues to evolve.
Transcript
I would very much advocate for patients to bring any clinical or research information they have to discuss with their healthcare providers.
The healthcare provider can help guide them through these data, as they tend to be complicated and may or may not apply to their type of amyloidosis.
That all being said, the field is evolving rapidly. The providers may not be aware of new trials or evolving indications for current therapies.